Including the 1st international Symposium of Golden Syrian Hamster Disease Models

27-28th October 2018, Zhengzhou China

Immunotherapy is becoming a mainstream approach for many cancer types. However, the antitumour efficacy, especially for human solid tumours, is still limited. This requires further comprehensive understanding of the basic mechanisms underlying tumour-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Symposium is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer, and to present the latest uses of personalized cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in encouraging responses.

To better understand tumour immunology and immunity as well to develop more effective therapies, the demand for predictive and robust preclinical models to minimize translational failures in immuno-oncology is at an all-time high. The golden Syrian hamster is one of the most valuable animal models for recapitulating some important human diseases. Part of the meeting is designed to feature and discuss cutting-edge complex immunocompetent and transgenic Syrian hamster models for cancer research, cardiovascular diseseases and viral infections as well as to present case studies of their successful applications.

Target Audience

• Cancer research Students, Scientists

• Cancer research Faculty

• Oncologists

• Cardiovasculargist

• Medical Colleges

• Cancer research Associations and Societies

• Business Entrepreneurs

• Training Institutes

• Manufacturing Medical Devices Companies

Venue: Sheradon Hotel, Zhengzhou(No.33 Jinshui Dong Road, CBD, Zhengzhou)

Chair of the symposium: Nick Lemoine

Invited speakers:

1) Prof William Wold, Professor& Chairman, Department of Molecular Microbiology & Immunology, Saint Louis University School of Medicine

2) Prof Zhongde Wang, Department of Animal, Dairy, and Veterinary Sciences Utah State University

3) Prof Robbert Cormier: Department of Biomedical Sciences, University of Minnesota,

4) Prof Michail Sitkovsky, Black Chair Professor of Immunophysiology and Pharmaceutical Biotechnology Director New England Inflammation and Tissue Protection Institute Northeastern University

5) Prof. Ingolf Blasig, Molecular Cell Physiology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Forschungsverbund Berlin, Germy

6) Dr. Hua Wu, Senior Vice President, Vaccine & Antibody Development, SAB Biotherapeutics Inc.

7) Prof. Xudong Zhang, Faculty of Medicine and Public Health, University of Newcastle, NSW, Australia

8) Prof Bo Huang, Peking Union Medical School

9) Prof Zhijie Chang, Qinghua University, Cancer Biology

10) Prof Yulong He, Suzhou University, Lymphogenesis and cancer metastasis

11) Prof Xiaofeng Qin, Institute of Systemic Biology, CAMS, Suzhou

12) Prof Guoqing (George) Liu, Peking University

13) Prof Shengdian Wang, Chinese Academy of Sciences

14) Prof Jianzeng Dong, Capital University of Medicial Sciences

15) Prof. Mian Wu, School of Life Science,University of Science and Technology of China, recruited as“100-talents Program” from CAS

16) Jinming Li, Professor and Chair, Department of Bioinformatics, Southern Medical University

17) Prof. Taoyong Chen，The Second Military Medical University，”Changjiang Scholar”

18) Prof. Yuting Ma, Center of Systems Medicine, Chinese Academy of Medical Sciences, Suzhou Institute of Systems Medicine

19) Prof. Angang Yang, the Fourth Military Medical University

Agenda

27th October

15:30-16:00 Opening Ceremony

16:00-18:30 Presentations

28th October

9:00-12:00 Presentations

12:00 Lunch

14:00-18:00 Presentations

The Academy of Medical Sciences

Zhengzhou University

28 September, 2018